Sage Therapeutics

Sage Therapeutics company information, Employees & Contact Information

Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and change how brain disorders are thought about and treated. Our mission is to pioneer solutions with the potential to deliver life-changing brain health medicines, so every person can thrive. Welcome To The Workplace With A Difference At Sage, we believe that life is more than just a destination. We’re concerned with the journey, and we care deeply about everyone contributing to and benefiting from our own company journey. This means helping people discover the right path for them and carefully guiding colleagues along the way. Read our Community Guidelines: http://bit.ly/2tFyAoj

Company Details

Employees
451
Founded
-
Address
215 First Street, Cambridge,ma 02142,united States
Phone
6172998379
Email
ca****@****erx.com
Industry
Biotechnology Research
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)
Website
sagerx.com
HQ
Cambridge, MA
Looking for a particular Sage Therapeutics employee's phone or email?

Sage Therapeutics Questions

News

Sage Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, April 29, 2025 - Business Wire

Sage Therapeutics to Report First Quarter 2025 Financial Results on Tuesday, April 29, 2025 Business Wire

Sage Therapeutics Appoints Jessica Federer to Board of Directors - Sage Therapeutics

Sage Therapeutics Appoints Jessica Federer to Board of Directors Sage Therapeutics

Sage Therapeutics Confirms Receipt of Unsolicited Nonbinding Acquisition Proposal from Biogen - Business Wire

Sage Therapeutics Confirms Receipt of Unsolicited Nonbinding Acquisition Proposal from Biogen Business Wire

Sage Therapeutics Announces U.S. Drug Enforcement Administration Scheduling of ZULRESSO™ (brexanolone) Injection - Sage Therapeutics

Sage Therapeutics Announces U.S. Drug Enforcement Administration Scheduling of ZULRESSO™ (brexanolone) Injection Sage Therapeutics

Sage Therapeutics to Present at Upcoming September Investor Conferences | User | poteaudailynews.com - FinancialContent

Sage Therapeutics to Present at Upcoming September Investor Conferences | User | poteaudailynews.com FinancialContent

Sage Therapeutics to Host Sage FutureCast Webcast - FinancialContent

Sage Therapeutics to Host Sage FutureCast Webcast FinancialContent

Sage Therapeutics Board of Directors Initiates Review of Strategic Alternatives and Rejects Biogen’s Unsolicited Acquisition Proposal - Business Wire

Sage Therapeutics Board of Directors Initiates Review of Strategic Alternatives and Rejects Biogen’s Unsolicited Acquisition Proposal Business Wire

Sage Therapeutics to Host Conference Call - FinancialContent

Sage Therapeutics to Host Conference Call FinancialContent

Sage Therapeutics Announces First Quarter 2025 Financial Results and Highlights Pipeline and Business Updates - Business Wire

Sage Therapeutics Announces First Quarter 2025 Financial Results and Highlights Pipeline and Business Updates Business Wire

Sage Therapeutics Launches SageCitizen Social Impact Initiative - FinancialContent

Sage Therapeutics Launches SageCitizen Social Impact Initiative FinancialContent

Sage Therapeutics to Present at the Morgan Stanley Global Healthcare Conference | User | bigspringherald.com - FinancialContent

Sage Therapeutics to Present at the Morgan Stanley Global Healthcare Conference | User | bigspringherald.com FinancialContent

Top Sage Therapeutics Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant